石四药集团：盐酸贝尼地平片取得药品生产注册批件

Core Viewpoint - The company has obtained the production registration approval for Benidipine Hydrochloride Tablets (8mg) from the National Medical Products Administration of China, which is classified as a Class 4 chemical drug and is considered to have passed the consistency evaluation [1] Group 1 - The approval is significant for the treatment of primary hypertension and angina pectoris [1]